Skip to main content
Premium Trial:

Request an Annual Quote

Agencourt, Ambion Pen Reagent Distribution Deal

NEW YORK, Sept. 16 (GenomeWeb News) - Agencourt Bioscience said today that it has signed a distribution agreement with Ambion for its SPRI (Solid-Phase Reversible Immobilization) nucleic acid purification reagent.

Under the terms of the agreement, Ambion will distribute the reagent, called AMPure, as part of its MessageAmp RNA amplification kit.

Further details about the agreement were not provided.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.